Yoon Sook Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yoon Sook Cho has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Dong Yoon Kang
Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine , Ulsan
2 shared publications - Hye-Ryun Kang
Drug safety Center, Seoul National University Hospital, Seoul, Korea
2 shared publications - Ju-Yeun Lee
College of Pharmacy, Seoul National University, Seoul, Korea
2 shared publications - A Jeong Kim
Department of Pharmacy, Seoul National University Hospital, Seoul 03080, Korea
1 shared publication Bcop
1 shared publicationBo Min Jang
Department of Pharmacy Seoul National University Hospital Seoul Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Enhancing Medication History Accuracy in a Tertiary Hospital: Pharmacist‐Led Counseling With Nationwide Medication History Sharing Program Versus Conventional Methods
Aims: Medication discrepancies during transitions of care pose substantial risks, particularly in older patients receiving complex medication regimens. Obtaining the best possible medication history (BPMH) is crucial to minimize this risk. This study aimed to evaluate the effectiveness of a pharmacist‐led BPMH using various information sources including a nationwide medication history sharing program compared to conventional interviews in a tertiary hospital setting. In addition, we identified factors contributing to medication inaccuracies.Methods: A single‐center prospective study involving older patients scheduled for thoracic surgery at a tertiary hospital was conducted. Medication histories obtained through conventional interviews during the initial assessment on admission were compared with those obtained through BPMH by pharmacist‐led interviews. Logistic regression analysis was used to identify factors associated with medication inaccuracies.Results: This study included 216 patients, a significant proportion of whom were experiencing polypharmacy. The pharmacist‐led BPMH approach demonstrated superior accuracy in documenting medication histories, with conventional methods showing inaccuracies in over 70% of the cases. Factors that significantly increased the likelihood of inaccuracies included the number of medications and number of prescribers. Nonoral and as‐needed medications are particularly prone to inaccuracies.Conclusions: Pharmacist‐led BPMH significantly improved medication history accuracy compared to conventional methods, which had inaccuracies in over 70%. It is important to be careful when obtaining BPMH for older adults, particularly those with complex medication regimens, nonoral medications, or PRN medications, to enhance patient safety and reduce medication‐related risks.Trial Registration: Clinical Trial Registry identifier: KCT-006813.
- 1 January 2024
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2024 (1)
Open AccessEnhancing Medication History Accuracy in a Tertiary Hospital: Pharmacist‐Led Counseling With Nationwide Medication History Sharing Program Versus Conventional Methods
Aims: Medication discrepancies during transitions of care pose substantial risks, particularly in older patients receiving complex medication regimens. Obtaining the best possible medication history (BPMH) is crucial to minimize this risk. This study aimed to evaluate the effectiveness of a pharmacist‐led BPMH using various information sources including a nationwide medication history sharing program compared to conventional interviews in a tertiary hospital setting. In addition, we identified factors contributing to medication inaccuracies.Methods: A single‐center prospective study involving older patients scheduled for thoracic surgery at a tertiary hospital was conducted. Medication histories obtained through conventional interviews during the initial assessment on admission were compared with those obtained through BPMH by pharmacist‐led interviews. Logistic regression analysis was used to identify factors associated with medication inaccuracies.Results: This study included 216 patients, a significant proportion of whom were experiencing polypharmacy. The pharmacist‐led BPMH approach demonstrated superior accuracy in documenting medication histories, with conventional methods showing inaccuracies in over 70% of the cases. Factors that significantly increased the likelihood of inaccuracies included the number of medications and number of prescribers. Nonoral and as‐needed medications are particularly prone to inaccuracies.Conclusions: Pharmacist‐led BPMH significantly improved medication history accuracy compared to conventional methods, which had inaccuracies in over 70%. It is important to be careful when obtaining BPMH for older adults, particularly those with complex medication regimens, nonoral medications, or PRN medications, to enhance patient safety and reduce medication‐related risks.Trial Registration: Clinical Trial Registry identifier: KCT-006813.
- Open Access
- 1 September 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (9) , 101704
Evaluation of off-label medication use and drug safety in a pediatric intensive care unit
Safety and efficacy are essential in the process of disease treatment. However, off-label medication use is inevitable because various medications do not contain regulatory labels for pediatric use. We aimed to examine off-label medication use and analyze the risk factors correlated with adverse drug reactions (ADRs). This study was performed retrospectively using electronic medical data from a pediatric intensive care unit (PICU) of a tertiary hospital in Korea from July 2019 to June 2020. A total 6,183 prescribed medications from 502 PICU patients were examined in the present study. A total of 80% were infants or children, and 96.0% of them were treated with off-label medications. It was discovered that 4,778 off-label cases (77.2%) of the top 100 drugs had prescriptions with dosage (67.8%). Drugs prescribed to patients admitted to the cardiothoracic department (odds ratio [OR], 3.248; p = 0.019), total number of medications (OR, 1.116; p = 0.001), and length of PICU stay of ≥ 7 days (OR, 4.981; p = 0.008) were significantly associated with ADRs. ADRs were noted to be more severe in off-label use (p = 0.0426). For appropriate medication use, evidence regarding the safety of off-label medications is required and ultimately reflected in the official regulation.
- 1 September 2023
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 31 (9) , 101704
Open AccessEvaluation of off-label medication use and drug safety in a pediatric intensive care unit
Safety and efficacy are essential in the process of disease treatment. However, off-label medication use is inevitable because various medications do not contain regulatory labels for pediatric use. We aimed to examine off-label medication use and analyze the risk factors correlated with adverse drug reactions (ADRs). This study was performed retrospectively using electronic medical data from a pediatric intensive care unit (PICU) of a tertiary hospital in Korea from July 2019 to June 2020. A total 6,183 prescribed medications from 502 PICU patients were examined in the present study. A total of 80% were infants or children, and 96.0% of them were treated with off-label medications. It was discovered that 4,778 off-label cases (77.2%) of the top 100 drugs had prescriptions with dosage (67.8%). Drugs prescribed to patients admitted to the cardiothoracic department (odds ratio [OR], 3.248; p = 0.019), total number of medications (OR, 1.116; p = 0.001), and length of PICU stay of ≥ 7 days (OR, 4.981; p = 0.008) were significantly associated with ADRs. ADRs were noted to be more severe in off-label use (p = 0.0426). For appropriate medication use, evidence regarding the safety of off-label medications is required and ultimately reflected in the official regulation.
- Open Access
- 1 April 2023
- Published by Korean Society for Parenteral and Enteral Nutrition/The Korean Society of Surgical Metabolism and Nutrition in Annals of Clinical Nutrition and Metabolism
- Vol. 15 (1) , 8-14
Selenium deficiency and supplementation in infants: a narrative review
Ji Young Lee, Min Jung Kang, Hyun Jeong Kim, Sung Yun Suh, Yoon Sook Cho, Sook Hee An. Ann Clin Nutr Metab 2023;15:8-14. https://doi.org/10.15747/ACNM.2023.15.1.8
- 1 April 2023
- Published by Korean Society for Parenteral and Enteral Nutrition/The Korean Society of Surgical Metabolism and Nutrition in Annals of Clinical Nutrition and Metabolism
- Vol. 15 (1) , 8-14
Open AccessSelenium deficiency and supplementation in infants: a narrative review
Ji Young Lee, Min Jung Kang, Hyun Jeong Kim, Sung Yun Suh, Yoon Sook Cho, Sook Hee An. Ann Clin Nutr Metab 2023;15:8-14. https://doi.org/10.15747/ACNM.2023.15.1.8
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (44) , e346
Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study
Kang H, et al. J Korean Med Sci. 2023 Oct;38:e346. https://doi.org/10.3346/jkms.2023.38.e346
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (44) , e346
Open AccessAdverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study
Kang H, et al. J Korean Med Sci. 2023 Oct;38:e346. https://doi.org/10.3346/jkms.2023.38.e346
- Open Access
- 30 September 2022
- Published by Korean Society for Pharmacoepidemiology and Risk Management in Journal of Pharmacoepidemiology and Risk Management
- Vol. 14 (2) , 149-157
Real-world Data-based Adverse Drug Reactions Analysis of Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma
Minoh Ko, PharmD, MS, BCOP, Jieun Choi, PharmD, Sujin Kim, PharmD, Sung Hwan Kim, MS, Eun Jung Cho, BPharm, Yoon Sook Cho, PhD, Young Il Koh, MD, PhD and Jung Mi Oh, PharmD. Journal of Pharmacoepidemiology and Risk Management 2022;14:149-57. https://doi.org/10.56142/jperm.22.0014
- 30 September 2022
- Published by Korean Society for Pharmacoepidemiology and Risk Management in Journal of Pharmacoepidemiology and Risk Management
- Vol. 14 (2) , 149-157
Open AccessReal-world Data-based Adverse Drug Reactions Analysis of Pomalidomide in Patients with Relapsed or Refractory Multiple Myeloma
Minoh Ko, PharmD, MS, BCOP, Jieun Choi, PharmD, Sujin Kim, PharmD, Sung Hwan Kim, MS, Eun Jung Cho, BPharm, Yoon Sook Cho, PhD, Young Il Koh, MD, PhD and Jung Mi Oh, PharmD. Journal of Pharmacoepidemiology and Risk Management 2022;14:149-57. https://doi.org/10.56142/jperm.22.0014
- Open Access
- 15 May 2020
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 45 (4) , 767-773
Effect of post‐operative anticoagulation management in patients who have undergone On‐X mechanical heart valve replacement surgery on post‐discharge warfarin therapy
What is known and objective We evaluated the effect of the proportion of time maintained within the target international normalized ratio (INR) postoperatively in hospitalized patients who underwent On‐X mechanical heart valve replacement on warfarin therapy after discharge. Methods Inclusion was patients who were ≥18 years, received warfarin for a minimum of 10 days without any interruptions during hospitalization and followed by the anticoagulation service (ACS) clinic after discharge between June 2006 and June 2016. Patients were excluded if they had incomplete medical records, INR goal changes, known as warfarin resistance, transferred to another facility or expired during the study. The patients were divided into 3 groups according to the proportion of time maintained within therapeutic INR range (TTR) from day 4 to 10 of warfarin initiation (low: P = .007). Additionally, the low group had more ACS visits than the high group (low, 6.6 ± 5.2 vs high, 4.6 ± 3.9; P = .025). Patient compliance affected the time needed to reach target INR for 2 consecutive measurements (compliant, 42.36 ± 58.5 days vs non‐compliant, 132.0 ± 157.1 days, P < .001). What is new and conclusion The study implicated that high postoperative TTR would reduce the time to require post‐discharge target INR and the number of ACS visits.
- 15 May 2020
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 45 (4) , 767-773
Open AccessEffect of post‐operative anticoagulation management in patients who have undergone On‐X mechanical heart valve replacement surgery on post‐discharge warfarin therapy
What is known and objective We evaluated the effect of the proportion of time maintained within the target international normalized ratio (INR) postoperatively in hospitalized patients who underwent On‐X mechanical heart valve replacement on warfarin therapy after discharge. Methods Inclusion was patients who were ≥18 years, received warfarin for a minimum of 10 days without any interruptions during hospitalization and followed by the anticoagulation service (ACS) clinic after discharge between June 2006 and June 2016. Patients were excluded if they had incomplete medical records, INR goal changes, known as warfarin resistance, transferred to another facility or expired during the study. The patients were divided into 3 groups according to the proportion of time maintained within therapeutic INR range (TTR) from day 4 to 10 of warfarin initiation (low: P = .007). Additionally, the low group had more ACS visits than the high group (low, 6.6 ± 5.2 vs high, 4.6 ± 3.9; P = .025). Patient compliance affected the time needed to reach target INR for 2 consecutive measurements (compliant, 42.36 ± 58.5 days vs non‐compliant, 132.0 ± 157.1 days, P < .001). What is new and conclusion The study implicated that high postoperative TTR would reduce the time to require post‐discharge target INR and the number of ACS visits.
- Open Access
- 1 January 2017
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 5 (4) , 228-231
A case series of eperisone-induced immediate hypersensitivity
강동윤, et al. Allergy Asthma Respir Dis. 2017 Jul;5(4):228-231. https://doi.org/10.4168/aard.2017.5.4.228
- 1 January 2017
- Published by XMLink in Allergy Asthma & Respiratory Disease
- Vol. 5 (4) , 228-231
Open AccessA case series of eperisone-induced immediate hypersensitivity
강동윤, et al. Allergy Asthma Respir Dis. 2017 Jul;5(4):228-231. https://doi.org/10.4168/aard.2017.5.4.228
- Open Access
- 30 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1435
Multidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea
In order to improve the reporting of adverse drug reactions (ADRs) as part of the routine practice at the pediatric outpatient department (OPD), we modified our ADR reporting strategy into one that facilitates the reporting process by means of a multi-disciplinary approach. In this study, we retrospectively reviewed ADR records during the period from March to September 2014 when we changed our reporting process as a part of institutional quality assurance (QA) activity. Yearly differences in the number and composition of ADRs were compared, and the descriptive analyses were done for cases reported from OPD during the QA activity in terms of the suspected drugs, type, causality, and severity of ADRs. There were 1211 pediatric ADR reports including 520 cases with underlying hemato-oncologic diseases during the period of 2014. Among the 691 non-oncologic cases, 76 were reported from the OPD, which was a significant increase (347 %) from the 17 cases reported during the previous year. Further analyses of these 76 cases revealed that the caregivers (47.4 %) initiated about half of the reports, the most frequently affected organ was the skin (32.9 %), and the most frequent suspected drugs were anticonvulsants (14.5 %). In contrast to the in-ward system, moderate cases were more frequent (51.3 %) than mild ones. In conclusion, this study provides a profile of pediatric ADRs in the OPD, which were largely under-reported during the usual clinical practice. A multi-disciplinary approach would improve spontaneous ADR reporting at the pediatric OPD.
- 30 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1435
Open AccessMultidisciplinary approach to improve spontaneous ADR reporting in the pediatric outpatient setting: a single-institute experience in Korea
In order to improve the reporting of adverse drug reactions (ADRs) as part of the routine practice at the pediatric outpatient department (OPD), we modified our ADR reporting strategy into one that facilitates the reporting process by means of a multi-disciplinary approach. In this study, we retrospectively reviewed ADR records during the period from March to September 2014 when we changed our reporting process as a part of institutional quality assurance (QA) activity. Yearly differences in the number and composition of ADRs were compared, and the descriptive analyses were done for cases reported from OPD during the QA activity in terms of the suspected drugs, type, causality, and severity of ADRs. There were 1211 pediatric ADR reports including 520 cases with underlying hemato-oncologic diseases during the period of 2014. Among the 691 non-oncologic cases, 76 were reported from the OPD, which was a significant increase (347 %) from the 17 cases reported during the previous year. Further analyses of these 76 cases revealed that the caregivers (47.4 %) initiated about half of the reports, the most frequently affected organ was the skin (32.9 %), and the most frequent suspected drugs were anticonvulsants (14.5 %). In contrast to the in-ward system, moderate cases were more frequent (51.3 %) than mild ones. In conclusion, this study provides a profile of pediatric ADRs in the OPD, which were largely under-reported during the usual clinical practice. A multi-disciplinary approach would improve spontaneous ADR reporting at the pediatric OPD.